Denosumab is the active ingredient for Prolia as well as Xgeva, with Prolia being a treatment for osteoporosis and osteopenia, and Xgeva being a drug used for the prevention of skeletal-related events in adults with bone metastases from solid tumors. Both Prolia and Xgeva come from biotech pharmaceutical company Amgen Inc. An emerging drug … [Read more...]